TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CRBU

Caribou Biosciences Inc

Healthcare · Biotechnology

1.20$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CRBU
Line item 2019 2020 2021 2022 2023 2024 2025
-553.0% -268.7% -338.8% -656.7% -270.6% -1,382.8% -994.6%
13.0% 7.3% 10.3% 11.7% 10.2% 39.3% 32.7%
21.3% 8.1% 35.9% 84.6% 39.9% 167.2% 113.6%
-18.3% 0.1% 19.5% 84.6% – – –
-142.8% 1.4% 302.8% -30.4% -21.2% -51.2% -4.3%
15.3% 10.6% 32.5% 50.9% 33.7% 65.1% 12.2%
470.5% 51.5% -1,837.9% -673.2% -197.8% 866.6% 916.2%
– – 4,505.1% – – – –
-0.8% 11.9% 10.7% 0.0% – – –
3.0% 14.0% 4,515.8% 15.4% 447.5% 167.3% 43.2%
-79.5% -203.2% 2,339.2% -1,314.6% -20.8% -348.9% -35.2%
-568.2% -279.3% -371.3% -707.7% -304.3% -1,447.9% -1,006.8%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?